Tirzepatide trials produced higher average reductions, with some participants achieving 20 to 22% body weight reduction over a similar timeframe
Preparation of Injection Solutions If preparing syringes for injection (whether for research in vivo administration or other purposes): Syringe selection: Use sterile, insulin-grade syringes (typically 29-31 gauge) for subcutaneous injection
History of pancreatitis: Semaglutide has been shown to increase the risk of pancreatitis, a condition characterized by inflammation of the pancreas
How Each Medication Is Taken Both semaglutide and tirzepatide are given as a small once-weekly injection under the skin, usually in the abdomen, thigh, or upper arm, and both use simple pen or syringe delivery that patients learn to do at home
You can also report suspected adverse reactions to any medicine, including unlicensed products, through the MHRA Yellow Card Scheme at Reports from patients and healthcare professionals contribute to national pharmacovigilance and help protect others